Hester Biosciences Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Strong return on equity (ROE 15.9%)
- Efficient capital deployment (ROCE 15.2%)
- Attractively valued vs sector (P/E 32.9x vs industry 50.2x)
Concerns
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,758 | ₹4.2L Cr | 33.2 | 5.05 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,559 | ₹2.4L Cr | 79.8 | 15.15 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,557 | ₹1.7L Cr | 79.3 | 9.43 | 27.4 | 15.2 | 0.77 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,176 | ₹1.1L Cr | 23.1 | 4.37 | 21.2 | 21.1 | 0.38 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,137 | ₹1.1L Cr | 52.8 | 12.35 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,366 | ₹1.1L Cr | 30.2 | 3.21 | 11.6 | 15.5 | 0.01 |
| LAURUSLABS Laurus Labs Limited | ₹2,182 | ₹1.1L Cr | 97.4 | 22.22 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
HESTERBIO · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 53.73% | 53.73% | 53.73% | 53.73% | 53.73% | 53.73% |
| FII | 0.43% | 0.43% | 0.52% | 0.61% | 0.59% | 0.87% |
| DII | — | — | — | — | 0.02% | 0.02% |
| Public | 45.83% | 45.84% | 45.74% | 45.66% | 45.65% | 45.38% |
Latest News
All newsHester Biosciences to invest in captive power via LLP
*Hester Biosciences to invest in captive power via LLP.* The board approved investment in a Limited Liability Partnership for setting up group captive power generation. This move aims to ensure stable power supply for operations. Compliance with SEBI LODR regulations disclosed in filing. 📊 *STOCKS:* $HESTERBIO | 🏢 *SECTOR:* Corporate | #LOWIMPACT #Investment
Hester Biosciences reports Q1 FY26 financial results
*Hester Biosciences reports Q1 FY26 financial results*. Hester Biosciences has announced its financial results for the quarter ended June 30, 2026. The company reported **revenue of ₹123.4 crore** and **net profit of ₹18.7 crore**. Results reflect stable growth in animal healthcare demand. 📊 *STOCKS:* $HESTERBIO | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Earnings
Hester Biosciences releases Q1 FY27 results
*Hester Biosciences releases Q1 FY27 results* reports financial performance for the first quarter of fiscal 2027. The company shared key operational and revenue updates in line with market expectations. No major surprises were noted in the commentary or figures. 📊 *STOCKS:* $HESTERBIO | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Earnings
Hester Biosciences to host investor meet for analyst updates.
*Hester Biosciences to host investor meet for analyst updates.* The company has scheduled a call with analysts and institutional investors to share business updates. This event aims to improve transparency and investor engagement. No financial figures or major announcements were disclosed. 📊 *STOCKS:* $HESTERBIO | 🏢 *SECTOR:* Pharma | #LOWIMPACT #InvestorMeet
Hester Biosciences to invest in captive power via LLP
*Hester Biosciences to invest in captive power via LLP.* The company has filed under SEBI Listing Regulations for investment in an LLP for group captive power generation. This move aims to strengthen energy security for its operations. No financial details like **₹ amount** or **ROI** were disclosed. 📊 *STOCKS:* $HESTERBIO | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Investment
Hester Biosciences promoters reclassified as public shareholders
*Hester Biosciences promoters reclassified as public shareholders.* Mr. Ravin Gandhi and Ms. Bela Gandhi, previously under Promoter category, are now classified under Public shareholders. This reflects a shift in shareholding pattern but does not imply immediate sale or pledge. Regulatory filings indicate no change in shareholding percentage. 📊 *STOCKS:* $HESTERBIO | 🏢 *SECTOR:* Pharma | #LOWIMPACT #ShareholdingPattern
Hester Biosciences concludes shareholder postal ballot meeting
*Hester Biosciences concludes shareholder postal ballot meeting.* The company has shared voting results from its postal ballot with the exchange. A scrutinizers report and minutes of the meeting have also been submitted. This follows standard corporate procedure for shareholder approvals. 📊 *STOCKS:* $HESTERBIO | 🏢 *SECTOR:* Pharma | #LOWIMPACT #ShareholderMeeting
Hester Biosciences publishes newspaper notice for general meeting
*Hester Biosciences publishes newspaper notice for upcoming general meeting.* The filing is a routine regulatory requirement for convening shareholder meetings. No financial or operational updates were included. **No immediate market-moving details** were disclosed in the notice. 📊 *STOCKS:* $HESTERBIO | 🏢 *SECTOR:* Pharma | #LOWIMPACT #CorporateFiling
Hester Biosciences publishes statutory notice in newspaper
Hester Biosciences has published a statutory notice in a newspaper as part of regulatory compliance. The filing is a routine corporate disclosure with no operational or financial implications. Such notices are standard practice for listed companies. 📊 *STOCKS:* HESTERBIO | 🏢 *SECTOR:* Pharma | #LOWIMPACT #corporate_filing
Hester Biosciences publishes newspaper notice for compliance
*Hester Biosciences publishes newspaper notice for compliance.* This is a routine regulatory filing made in accordance with SEBI guidelines. The notice does not disclose any financial results or strategic developments. Such publications are standard practice for listed companies. 📊 *STOCKS:* HESTERBIO | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Compliance
About Hester Biosciences Limited
Hester Biosciences Ltd is one of the leading animal health care companies & the second largest poultry vaccine manufacturer in India. Founded by Mr. Rajiv Gandhi in 1987, it has now a presence in over 30 countries & has a key market in India, Nepal & Tanzania. It has partnered with Bill & Melinda Gates Foundation, GALVmed, Golchha Organisation, Novapharma, etc. While operating across four broad verticals of Poultry Vaccines, Poultry Health Products, Animal Vaccines and Animal Health Products, the company provides services like seroprofiling kits and diagnostic labs for poultry flocks, and mastitis control programs for cattle.[1]
HealthcarePharmaceuticals & Biotechnology